# OrthoSensor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orthosensor

- Industry: Medical Devices & Equipment
- Headquarters: Dania Beach, US
- Website: www.orthosensor.com
- Total disclosed funding: $66M
- Latest round: Series C (Feb 27, 2015)
- Investors on record: 4

## About

OrthoSensor, Inc. is a medical technology company specializing in advanced sensor solutions that enhance surgical outcomes, particularly in orthopedics. Their innovative products provide critical data for surgical precision during procedures.Founded in 2006, OrthoSensor, Inc. operates from Dania Beach, US, focusing on developing sensor technology for orthopedic surgeries. The company was acquired by Stryker Corporation in January 2021, and has conducted 7 deals to date. The founders, Manuel Aguero and Martin Roche, laid the groundwork for the company’s innovative approach to surgery instrumentation.OrthoSensor specializes in advanced sensor technology designed to improve surgical outcomes, particularly in the field of orthopedics. The company's core offerings include its flagship product, the VERASENSE knee sensor, which provides real-time data during knee replacement surgeries. This device allows surgeons to measure and optimize implant positioning, improving alignment and stability while minimizing complications. The VERASENSE system is typically utilized in operating rooms, where medical professionals can leverage its insights to enhance patient outcomes. The company's primary customer base includes hospitals and surgical centers, predominantly within the United States, as well as select international markets in Europe and Asia, where orthopedic procedures are on the rise.OrthoSensor generates revenue primarily through the sale of its VERASENSE systems and associated disposable sensors utilized in surgical procedures. The company's transaction structure typically involves direct sales to healthcare providers, wherein hospitals purchase the sensor systems and recurring consumables needed for each surgery. This model creates a consistent revenue stream as clients rely on the technology for ongoing procedures. Pricing structures are aligned with the sophistication and effectiveness of the technology, providing value to healthcare providers through improved surgical outcomes and enhanced patient care. Partnerships with orthopedic device manufacturers may further facilitate distribution and integration of OrthoSensor's products into broader surgical workflows, enhancing the company’s market reach.With the recent acquisition by Stryker Corporation, OrthoSensor is positioned for strategic growth. The company is likely to focus on expanding the VERASENSE product line and may introduce new technologies aimed at enhancing surgical procedures. They plan to target further expansion into international markets, particularly in Europe and Asia, leveraging Stryker’s distribution network. The recent funding from the acquisition will support these initiatives, allowing OrthoSensor to enhance its product offerings and increase market penetration.

## Funding rounds

- Series C, Feb 27, 2015, $17M — Tullis Health Investors, Bridger Capital
- Series B, Oct 15, 2013, $13M — MediTech Partners, Dignity Health
- Series B, May 4, 2012, $15M — MediTech Partners
- Series B, Jan 27, 2011, $21M — MediTech Partners

## Investors

- MediTech Partners (https://capitalatlas.ai/funds/meditech-partners) — Series B
- Dignity Health — Series B
- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series C
- Bridger Capital — Series C